SCHEMBL28389907

SCHEMBL28389907

O=C(NN=Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1)c1ccncc1

nearest known ligand 0.93

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.93
RECQL P46063 1/20 0.93
SMN1; SMN2 Q16637 1/20 0.78
KMT2A Q03164 9/20 0.73
POLB P06746 7/20 0.73
TDP1 Q9NUW8 4/20 0.73
CTDSP1 Q9GZU7 2/20 0.73
PSMD14 O00487 2/20 0.73
THRB P10828 1/20 0.73
HPGD P15428 1/20 0.73
MEN1 O00255 5/20 0.72
ALDH1A1 P00352 3/20 0.72
L3MBTL1 Q9Y468 2/20 0.72
KDM4E B2RXH2 2/20 0.72
MAPK1 P28482 1/20 0.68
NT5E P21589 1/20 0.63
DUSP3 P51452 1/20 0.60
PTPN5 P54829 1/20 0.60
PTPN11 Q06124 1/20 0.60
ASF1A Q9Y294 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28393986 1.00 MAPT (0.93) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL12443129 0.91 SMN1; SMN2 (0.89) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28390365 0.89 RAB9A (0.74) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28390366 0.89 RAB9A (0.74) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28395216 0.88 MAPT (0.72) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28390518 0.88 KMT2A (0.93) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28395587 0.88 MAPT (0.72) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28888709 0.88 KMT2A (0.93) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28393332 0.87 MAPT (0.75) MAPTRECQLSMN1; SMN2KMT2APOLB
SCHEMBL28392611 0.87 MAPT (0.71) MAPTRECQLSMN1; SMN2KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116464-B (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2022-09-13 CN claimed
CN-111116464-A (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2020-05-08 CN claimed
CN-111116464-B (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2022-09-13 CN disclosed
CN-111116464-A (E) -4- (pyridylformylhydrazono) -N-phenylbenzamide antitumor compounds 中国医科大学 2020-05-08 CN disclosed